These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1176 related articles for article (PubMed ID: 29920246)

  • 1. Alzheimer's disease in the omics era.
    Sancesario GM; Bernardini S
    Clin Biochem; 2018 Sep; 59():9-16. PubMed ID: 29920246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
    Tebani A; Afonso C; Marret S; Bekri S
    Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omics-based biomarkers discovery for Alzheimer's disease.
    Aerqin Q; Wang ZT; Wu KM; He XY; Dong Q; Yu JT
    Cell Mol Life Sci; 2022 Nov; 79(12):585. PubMed ID: 36348101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multi-omics technology and its applications to life sciences: a review].
    Liu J; Li W; Wang L; Li J; Li E; Luo Y
    Sheng Wu Gong Cheng Xue Bao; 2022 Oct; 38(10):3581-3593. PubMed ID: 36305394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Data analysis methods for defining biomarkers from omics data.
    Li C; Gao Z; Su B; Xu G; Lin X
    Anal Bioanal Chem; 2022 Jan; 414(1):235-250. PubMed ID: 34951658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Omic Technologies in Alzheimer's Disease.
    Avramouli A; Vlamos PM
    Adv Exp Med Biol; 2017; 987():177-184. PubMed ID: 28971457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study.
    Xicota L; Ichou F; Lejeune FX; Colsch B; Tenenhaus A; Leroy I; Fontaine G; Lhomme M; Bertin H; Habert MO; Epelbaum S; Dubois B; Mochel F; Potier MC;
    EBioMedicine; 2019 Sep; 47():518-528. PubMed ID: 31492558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
    Lista S; Zetterberg H; O'Bryant SE; Blennow K; Hampel H
    Methods Mol Biol; 2017; 1598():101-115. PubMed ID: 28508359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissecting Alzheimer's Disease Molecular Substrates by Proteomics and Discovery of Novel Post-translational Modifications.
    Deolankar SC; Patil AH; Koyangana SG; Subbannayya Y; Prasad TSK; Modi PK
    OMICS; 2019 Jul; 23(7):350-361. PubMed ID: 31225774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics approaches to probe markers of disease resistance in animal sciences.
    Guillemin N; Horvatić A; Kuleš J; Galan A; Mrljak V; Bhide M
    Mol Biosyst; 2016 Jun; 12(7):2036-46. PubMed ID: 27197117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
    Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
    Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
    Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
    PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The application of multi-omics and systems biology to identify therapeutic targets in chronic kidney disease.
    Cisek K; Krochmal M; Klein J; Mischak H
    Nephrol Dial Transplant; 2016 Dec; 31(12):2003-2011. PubMed ID: 26487673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omics sciences for systems biology in Alzheimer's disease: State-of-the-art of the evidence.
    Hampel H; Nisticò R; Seyfried NT; Levey AI; Modeste E; Lemercier P; Baldacci F; Toschi N; Garaci F; Perry G; Emanuele E; Valenzuela PL; Lucia A; Urbani A; Sancesario GM; Mapstone M; Corbo M; Vergallo A; Lista S;
    Ageing Res Rev; 2021 Aug; 69():101346. PubMed ID: 33915266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases.
    Sun YV; Hu YJ
    Adv Genet; 2016; 93():147-90. PubMed ID: 26915271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New-generation high-throughput technologies based 'omics' research strategy in human disease].
    Yang X; Jiao R; Yang L; Wu LP; Li YR; Wang J
    Yi Chuan; 2011 Aug; 33(8):829-46. PubMed ID: 21831800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New molecular approaches to Alzheimer's disease.
    Di Resta C; Ferrari M
    Clin Biochem; 2019 Oct; 72():81-86. PubMed ID: 31018113
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 59.